Multiple MyelomaMyeloma ProteinsBoronic AcidsPyrazinesThalidomidePlasma CellsMelphalanParaproteinemiasMonoclonal Gammopathy of Undetermined SignificanceLeukemia, Plasma CellPlasmacytomaDexamethasoneTransplantation, AutologousSyndecan-1Bone MarrowAntineoplastic AgentsCell Line, TumorBence Jones ProteinParaproteinsImmunoglobulin Light ChainsAntineoplastic Combined Chemotherapy ProtocolsProteasome InhibitorsHematopoietic Stem Cell TransplantationOsteolysisBone DiseasesInterleukin-6Waldenstrom MacroglobulinemiaApoptosisChromosomes, Human, Pair 14Tumor Cells, CulturedMice, SCIDBone Marrow CellsImmunoglobulin kappa-ChainsDiphosphonatesVincristineSyndecansPrednisonePrognosisMaintenance ChemotherapyTreatment OutcomeImmunoglobulin lambda-ChainsAntineoplastic Agents, AlkylatingRemission InductionStem Cell TransplantationDrug Resistance, NeoplasmTranslocation, GeneticDoxorubicinGene Expression Regulation, NeoplasticCombined Modality TherapyRecurrenceSurvival AnalysisSurvival RateCyclophosphamideProtease InhibitorsStromal CellsChromosomes, Human, Pair 13Cell ProliferationHypergammaglobulinemiabeta 2-MicroglobulinAmyloidosisDisease-Free SurvivalFlow CytometryBone Marrow ExaminationSalvage TherapyDisease ProgressionCell SurvivalReceptors, Interleukin-6Chromosomes, Human, Pair 4Immunologic FactorsReceptor, Fibroblast Growth Factor, Type 3In Situ Hybridization, FluorescenceImmunoglobulin DNeoplasm ProteinsNeoplasms, Plasma CellDrug SynergismChromosome AberrationsOsteoclastsAntibodies, MonoclonalXenograft Model Antitumor AssaysImmunoglobulinsHematopoietic Stem Cell MobilizationPeripheral Blood Stem Cell TransplantationTransplantation ConditioningSignal TransductionAngiogenesis InhibitorsLymphomaImmunoglobulin AHematologic NeoplasmsB-LymphocytesOsteonecrosisInduction ChemotherapyRetrospective StudiesTime FactorsCell DivisionOxides